巨噬细胞炎性蛋白3α(MIP3a)活性蛋白
Active Macrophage Inflammatory Protein 3 Alpha (MIP3a)
CCL20; CKb4; LARC; MIP3-A; SCYA20; ST38; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 20; Beta-Chemokine Exodus-1; Liver And Activation-Regulated Chemokine
- 编号APA095Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 95%
- 等电点9.6
- 应用Cell culture; Activity Assays.
- 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1147 ¥ 2868 ¥ 5736 ¥ 17208 ¥ 43020
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
活性实验
Macrophage Inflammatory Protein 3 Alpha (MIP-3α), also known as LARC (liver and activation-regulated chemokine), Exodus-1 or CCL20, is a CC chemokine with a selective chemotactic activity for lymphocytes and dendritic cells (DCs). MIP3α is produced by activated cells, including monocytes, T cells, endothelial cells, epithelial cells, and fibroblasts and is expressed in liver, lung, and some lymphoid tissues. This chemokine elicits its effects on its target cells by binding to the chemokine receptor CCR7. It attracts certain cells of the immune system, including dendritic cells and antigen-engaged B cells, CCR7 central-memory T-Cells. Thus, chemotaxis assay used 24-well microchemotaxis system was undertaken to detect the chemotactic effect of recombinant human MIP-3α on the Jurkat cell line. Briefly, Jurkat cells were seeded into the upper chambers (200μL cell suspension,106 cells/mL in RPMI 1640 with FBS free) and MIP-3α (0.01ng/mL, 0.1ng/mL, 1ng/mL, 10ng/mL,100ng/mL and 1000ng/mL diluted separately in serum free RPMI 1640 ) was added in lower chamber with a polycarbonate filter (8 μm pore size) used to separate the two compartments. After incubation at 37℃ with 5% CO2 for 2h, the filter was removed, then cells in low chamber were observed by inverted microscope at low magnification (×100) and the number of migrated cells were counted at high magnification (×400) randomly (five fields for each filter). Result shows MIP-3α is able to induce migration of Jurkat cells. The migrated Jurkat cells in low chamber at low magnification (×100) were shown in Figure 1. Five fields of each chamber were randomly chosen, and the migrated cells were counted at high magnification (×400). Statistical results were shown in Figure 2. The optimum chemotaxis of recombinant human MIP-3α occurs at 1-10ng/mL.
Figure 2. The chemotactic effect of recombinant human MIP-3α on Jurkat cells
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPA095Hu01 | 巨噬细胞炎性蛋白3α(MIP3a)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu01 | 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 | Cell culture; Activity Assays. |
RPA095Hu02 | 巨噬细胞炎性蛋白3α(MIP3a)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu02 | 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 | Cell culture; Activity Assays. |
PAA095Hu01 | 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体 | WB; IHC; ICC; IP. |
PAA095Hu02 | 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体 | WB; IHC; ICC; IP. |
LAA095Hu71 | 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体(生物素标记) | WB; IHC; ICC. |
LAA095Hu81 | 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
MAA095Hu22 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB; IHC; ICC; IP. |
MAA095Hu23 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB; IHC; ICC; IP. |
MAA095Hu24 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB; IHC; ICC; IP. |
MAA095Hu25 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB; IHC; ICC; IP. |
MAA095Hu27 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB; IHC; ICC; IP. |
MAA095Hu21 | 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 | WB,IHC |
SEA095Hu | 巨噬细胞炎性蛋白3α(MIP3a)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA095Hu | 巨噬细胞炎性蛋白3α(MIP3a)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSA095Hu01 | 巨噬细胞炎性蛋白3α(MIP3a)检测试剂盒DIY材料(酶联免疫吸附试验法) | 自己动手制作ELISA试剂盒的主要材料 |
参考文献
杂志 | 参考文献 |
Medicine (Baltimore). | Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma [Pubmed:25396333] |
Cancer | Serum chemokine network correlates with chemotherapy in non-small cell lung cancer [PubMed: 25976768] |
American Journal of Cancer Research | CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. [pubmed:28560063] |
Biological Research | In vitro chemokine (CC motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis [10.1186:s40659-018-0161-z] |
BioMed Research International | Indoleamine 2, 3-Dioxygenase (IDO) Regulates Th17/Treg Immunity in Experimental IgA Nephropathy [] |